Wikidata

(Q40191245)

English

Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model

scientific article published on 20 December 2006

In more languages

Statements

title
Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17184908
retrieved
18 September 2017
author name string
Liang Zhang
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17184908
retrieved
18 September 2017
Xiaoping Zhang
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17184908
retrieved
18 September 2017
Glen W Barrisford
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17184908
retrieved
18 September 2017
Aria F Olumi
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17184908
retrieved
18 September 2017
publication date
20 December 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
17184908
retrieved
18 September 2017
page(s)
146-157
1 reference
stated in
Europe PubMed Central
PubMed ID
17184908
retrieved
18 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40191245&oldid=1888531543"